Perrigo Company PLC (PRGO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Perrigo Company PLC (PRGO) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($51.70 Million) by net assets ($4.45 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Perrigo Company PLC - Cash Flow Conversion Efficiency Trend (1991–2024)

This chart illustrates how Perrigo Company PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Perrigo Company PLC carry for a breakdown of total debt and financial obligations.

Perrigo Company PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Perrigo Company PLC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
J & J Snack Foods Corp
NASDAQ:JJSF
0.039x
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993
0.031x
Peloton Interactive Inc
NASDAQ:PTON
-0.220x
Grupo Televisa SAB ADR
NYSE:TV
0.115x
COSMO Pharmaceuticals SA
LSE:0RGI
0.002x
Shanxi Huaxiang Group Co Ltd
SHG:603112
-0.002x
Sinostone Guangdong Co Ltd
SHE:001212
0.012x
Shenzhen Urban Transport Planning Center Co. Ltd.
SHE:301091
N/A

Annual Cash Flow Conversion Efficiency for Perrigo Company PLC (1991–2024)

The table below shows the annual cash flow conversion efficiency of Perrigo Company PLC from 1991 to 2024. For the full company profile with market capitalisation and key ratios, see Perrigo Company PLC (PRGO) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $4.32 Billion $362.90 Million 0.084x -1.21%
2023-12-31 $4.77 Billion $405.50 Million 0.085x +34.01%
2022-12-31 $4.84 Billion $307.30 Million 0.063x +109.18%
2021-12-31 $5.15 Billion $156.30 Million 0.030x -73.03%
2020-12-31 $5.66 Billion $636.20 Million 0.113x +68.38%
2019-12-31 $5.80 Billion $387.80 Million 0.067x -36.14%
2018-12-31 $5.67 Billion $593.00 Million 0.105x -7.63%
2017-12-31 $6.17 Billion $698.90 Million 0.113x +3.03%
2016-12-31 $5.96 Billion $654.90 Million 0.110x -7.93%
2015-12-31 $10.04 Billion $1.20 Billion 0.119x +49.68%
2014-12-31 $8.69 Billion $693.50 Million 0.080x -0.01%
2013-12-31 $8.69 Billion $693.50 Million 0.080x -66.40%
2012-12-31 $2.33 Billion $553.80 Million 0.237x -14.32%
2011-12-31 $1.85 Billion $513.38 Million 0.277x +13.45%
2010-12-31 $1.53 Billion $373.96 Million 0.244x -15.36%
2009-12-31 $1.09 Billion $314.17 Million 0.289x +2.98%
2008-12-31 $921.92 Million $258.35 Million 0.280x +5.37%
2007-12-31 $933.72 Million $248.31 Million 0.266x +55.63%
2006-12-31 $754.47 Million $128.92 Million 0.171x -13.47%
2005-12-31 $640.74 Million $126.53 Million 0.197x +50.27%
2004-12-31 $590.84 Million $77.64 Million 0.131x -40.55%
2003-12-31 $536.23 Million $118.53 Million 0.221x +23.54%
2002-12-31 $448.42 Million $80.23 Million 0.179x -28.54%
2001-12-31 $416.14 Million $104.19 Million 0.250x +41.62%
2000-12-31 $385.88 Million $68.22 Million 0.177x -45.42%
1999-12-31 $363.75 Million $117.81 Million 0.324x +846.19%
1998-12-31 $354.80 Million $-15.40 Million -0.043x -167.25%
1997-12-31 $345.50 Million $22.30 Million 0.065x -68.35%
1996-12-31 $424.10 Million $86.50 Million 0.204x +6.65%
1995-12-31 $381.20 Million $72.90 Million 0.191x +53.62%
1994-12-31 $340.60 Million $42.40 Million 0.124x -33.72%
1993-12-31 $323.20 Million $60.70 Million 0.188x +38.35%
1992-12-31 $235.00 Million $31.90 Million 0.136x +29.88%
1991-12-31 $183.70 Million $19.20 Million 0.105x --

About Perrigo Company PLC

NYSE:PRGO USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.64 Billion
Market Cap Rank
#7003 Global
#2042 in USA
Share Price
$11.92
Change (1 day)
+0.68%
52-Week Range
$9.25 - $28.43
All Time High
$137.98
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nut… Read more